The study investigates NTC-801, a selective blocker of the acetylcholine-activated K(+) current (I(K,ACh)), as a potential treatment for atrial fibrillation (AF), focusing on its effects on various cardiac ionic currents.
NTC-801 effectively inhibited I(K,ACh) in atrial cells and reversed shortened action potential durations caused by stimulants, while having no effect on ventricular cells, indicating its atrial specificity.
In several AF models, NTC-801 showed significant antiarrhythmic effects, prolonging the atrial effective refractory period and converting AF to normal sinus rhythm, highlighting the role of I(K,ACh) in AF development and maintenance.